ProtekAI Overview

Status Private
Latest Deal Type Accelerator/​Inc
Investors 2

ProtekAI General Information


Operator of a biotechnology research agency intended to be used for the development of protein-based drugs. The company's research agency is working with a de novo fluorescent protein extracted from the marine organism Physalia, enabling clients to avail a new class of near-infrared fluorescent proteins, opening the door to a myriad of diagnostic & research applications

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • HI
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ProtekAI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 00000 Completed Startup
1. Early Stage VC 07-Dec-2010 00000 00000 00000 Completed Startup

ProtekAI Cap Table

To view ProtekAI‘s complete cap table, request access >>
Stock # of Shares
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000

ProtekAI Investors (2)

To view ProtekAI‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
University of Hawaii Foundation Limited Partner Minority 000 0000 000000 0
HiBEAM Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial